Tykerb & Letrozole (lapatinib)

pCPA File Number: 20748

Negotiation Status:

Negotiations were not pursued

Indication(s):

Early breast cancer, Metastatic breast cancer, Metastatic gastric cancer

Sponsor/Manufacturer:

GlaxoSmithKline Inc.

CDA-AMC Project Number:

PC0019-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

2013-08-09